Imaging of Multiple Myeloma

被引：10
|
作者：
Amos, Barry [1 ]
Agarwal, Amit [2 ]
Kanekar, Sangam [1 ,2 ]
机构：
[1] Penn State Univ, Dept Radiol, Hershey Med Ctr, 500 Univ Dr, Hershey, PA 17033 USA
[2] Penn State Univ, Dept Neurol, Hershey Med Ctr, 500 Univ Dr, Hershey, PA 17033 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2016年 / 30卷 / 04期
关键词：
Imaging; Multiple myeloma; Classification; Treatment; Complications; CENTRAL-NERVOUS-SYSTEM; STEM-CELL TRANSPLANTATION; GROUP CONSENSUS STATEMENT; WORKING GROUP; MANAGEMENT; GUIDELINES; DISORDERS; THERAPY; DISEASE; INVOLVEMENT;
D O I：
10.1016/j.hoc.2016.03.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Multiple myeloma is the most common bone malignancy. Multiple myeloma and related plasma cell proliferative disorders have a diverse set of clinicopathologic findings and yet, at times, it may be challenging for clinicians to clinch the diagnosis. Imaging plays an important role in identifying the extent of the disease, guiding biopsies, and diagnosing associated spinal and intracranial complications. The purpose of this review article is to describe the imaging findings associated with common neurologic complications seen with multiple myeloma and related plasma cell proliferative disorders (PCPDs).
引用
收藏
页码：843 / +
页数：24
相关论文
共 50 条
  • [41] Emerging Data on Management and Imaging of Myeloma Bone Disease
    Dimopoulos, Meletios A.
    Gavriatopoulou, Maria
    Terpos, Evangelos
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S80 - S82
  • [42] Infiltration of the spinal cord and peripheral nerves in multiple myeloma
    Su, Xiaoyun
    Kong, Xiangquan
    Kong, Xiangchuang
    Lu, Zuneng
    Zheng, Chuansheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Current Treatment Strategies for Multiple Myeloma at First Relapse
    Mavrothalassitis, Evangelos
    Triantafyllakis, Konstantinos
    Malandrakis, Panagiotis
    Gavriatopoulou, Maria
    Kleber, Martina
    Ntanasis-Stathopoulos, Ioannis
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (05)
  • [44] Kidney transplantation in multiple myeloma in 2023: A short review
    Avila, Goncalo
    Roldao, Marisa
    Ferreira, Hugo
    Coelho, Ines
    Chuva, Teresa
    Paiva, Ana
    Costa, Jose Maximino
    CLINICAL NEPHROLOGY, 2024, 102 (05) : 306 - 311
  • [45] Extramedullary disease in multiple myeloma - controversies and future directions
    Sevcikova, Sabina
    Minarik, Jiri
    Stork, Martin
    Jelinek, Tomas
    Pour, Ludek
    Hajek, Roman
    BLOOD REVIEWS, 2019, 36 : 32 - 39
  • [46] In Vitro Efficacy of Naftifine Against Lymphoma and Multiple Myeloma
    Schmeel, Leonard Christopher
    Schmeel, Frederic Carsten
    Blaum-Feder, Sabine
    Schmidt-Wolf, Ingo G. H.
    ANTICANCER RESEARCH, 2015, 35 (11) : 5921 - 5926
  • [47] Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper
    Kaiser, Martin
    Goh, Vicky
    Stern, Simon
    Spencer, Nicholas
    Rabin, Neil
    Ramasamy, Karthik
    Lawless, Sarah
    Soutar, Richard
    Ashcroft, John
    Pratt, Guy
    Messiou, Christina
    Bygrave, Ceri
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (04) : 1319 - 1325
  • [48] Imaging in multiple myeloma: How? When?
    Zamagni, Elena
    Tacchetti, Paola
    Cavo, Michele
    BLOOD, 2019, 133 (07) : 644 - 651
  • [49] PET/MR Imaging of Multiple Myeloma
    Shah, Shetal N.
    Oldan, Jorge D.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2017, 25 (02) : 351 - +
  • [50] Screening whole spine magnetic resonance imaging in multiple myeloma
    Wight, J.
    Stillwell, A.
    Morris, E.
    Grant, B.
    Lai, H. C.
    Irving, I.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (07) : 762 - 765
12345